Table 3.
Resistance profile of CRKP strains colonized in the intestine.
| Antibiotics | Total (n = 54) n (%) | Infection group (n = 13) n (%) | Colonization group (n = 41) n (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| R | I | S | R | I | S | R | I | S | |
| TGC | 7 (13.0) | 24 (44.4) | 23 (42.6) | 2 (15.4) | 9 (69.2) | 2 (15.4) | 5 (12.2) | 15 (36.6) | 21 (51.2) |
| COL | 4 (7.4) | – | 50 (92.6) | 2 (15.4) | – | 11 (84.6) | 2 (7.4) | – | 39 (95.1) |
| AMK | 22 (40.7) | 1 (1.9) | 31 (57.4) | 8 (61.5) | 0 | 5 (38.5) | 14 (34.1) | 1 (2.5) | 26 (63.4) |
| CZA | 9 (16.7) | – | 45 (83.3) | 2 (15.4) | – | 11 (84.6) | 7 (17.1) | – | 34 (82.9) |
| FOS | 30 (55.6) | 10 (18.5) | 14 (25.9) | 5 (38.5) | 5 (38.5) | 3 (25.9) | 25 (61.0) | 5 (12.2) | 11 (26.8) |
TGC, Tigecycline; COL, Colistin; AMK, Amikacin; CZA, Ceftazidime/Avibactam; FOS, Fosfomycin; R, Resistant; I, Intermediate; S, Susceptible; –, No Intermediate.